These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32910500)

  • 1. Proton pump inhibitors and odds of cholangiocarcinoma: A retrospective case-control study.
    Xiong J; Wang Y; Xu W; Liu Z; Wang H; Zhang Z; Han Y; Yin C; Cao S; Yang Z; Su T; Wei J; Chen G; Jin L
    Liver Int; 2020 Nov; 40(11):2848-2857. PubMed ID: 32910500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and the risk of cholangiocarcinoma: a hospital-based case-control study in China.
    Xiong J; Lu X; Xu W; Bai Y; Huang H; Bian J; Zhang L; Long J; Xu Y; Wang Z; Zhao H
    Cancer Manag Res; 2018; 10():3849-3855. PubMed ID: 30288116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study.
    Peng YC; Lin CL; Hsu WY; Chow WK; Lee SW; Yeh HZ; Chen CC; Kao CH
    Front Pharmacol; 2018; 9():718. PubMed ID: 30018559
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin use and the risk of cholangiocarcinoma.
    Choi J; Ghoz HM; Peeraphatdit T; Baichoo E; Addissie BD; Harmsen WS; Therneau TM; Olson JE; Chaiteerakij R; Roberts LR
    Hepatology; 2016 Sep; 64(3):785-96. PubMed ID: 26940227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
    Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
    Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study.
    Kamsa-Ard S; Luvira V; Pugkhem A; Luvira V; Thinkhamrop B; Suwanrungruang K; Bhudhisawasdi V
    BMC Cancer; 2015 Oct; 15():776. PubMed ID: 26496745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Repeated Praziquantel treatment and Papillary, and Intrahepatic Cholangiocarcinoma.
    Luvira V; Kamsa-Ard S; Kamsa-Ard S; Luvira V; Srisuk T; Pugkhem A; Pairojkul C; Bhudhisawasdi V
    Ann Hepatol; 2018 Aug; 17(5):802-809. PubMed ID: 30145559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma.
    Hatia RI; Eluri M; Hawk ET; Shalaby A; Karatas E; Shalaby A; Abdelhakeem A; Abdel-Wahab R; Chang P; Rashid A; Jalal PK; Amos CI; Han Y; Armaghany T; Shroff RT; Li D; Javle M; Hassan MM
    Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1338-1347. PubMed ID: 37540502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
    J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
    Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pesticide exposure and risk of cholangiocarcinoma: A hospital-based matched case-control study.
    Pugkhem A; Kamsa-Ard S; Kamsa-Ard S; Luvira V; Luvira V; Bhudhisawasdi V
    Trop Med Int Health; 2024 May; 29(5):390-404. PubMed ID: 38481371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland.
    Barner-Rasmussen N; Pukkala E; Hadkhale K; Färkkilä M
    United European Gastroenterol J; 2021 Dec; 9(10):1128-1135. PubMed ID: 34533900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins are associated with a reduced risk of cholangiocarcinoma: a population-based case-control study.
    Peng YC; Lin CL; Hsu WY; Chang CS; Yeh HZ; Tung CF; Wu YL; Sung FC; Kao CH
    Br J Clin Pharmacol; 2015 Oct; 80(4):755-61. PubMed ID: 25808421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.
    Li H; Hu B; Zhou ZQ; Guan J; Zhang ZY; Zhou GW
    World J Surg Oncol; 2015 Apr; 13():161. PubMed ID: 25903488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea.
    Lee BS; Park EC; Park SW; Nam CM; Roh J
    World J Gastroenterol; 2015 Jan; 21(2):502-10. PubMed ID: 25593465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for extrahepatic cholangiocarcinoma: a case-control study in China.
    Zhou Z; Nie SD; Jiang B; Wang J; Lv P
    Eur J Cancer Prev; 2019 Jul; 28(4):254-257. PubMed ID: 30299315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case-control analysis.
    Brandi G; Di Girolamo S; Farioli A; de Rosa F; Curti S; Pinna AD; Ercolani G; Violante FS; Biasco G; Mattioli S
    Cancer Causes Control; 2013 May; 24(5):911-8. PubMed ID: 23408245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Incidence and Factors Affecting Survival of Patients With Cholangiocarcinoma in the United States.
    Mukkamalla SKR; Naseri HM; Kim BM; Katz SC; Armenio VA
    J Natl Compr Canc Netw; 2018 Apr; 16(4):370-376. PubMed ID: 29632056
    [No Abstract]   [Full Text] [Related]  

  • 19. Arsenic-contaminated drinking water and cholangiocarcinoma.
    Reyes D; Ganesan N; Boffetta P; Labgaa I
    Eur J Cancer Prev; 2023 Jan; 32(1):10-17. PubMed ID: 35044987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational exposure to asbestos and risk of cholangiocarcinoma: a population-based case-control study in four Nordic countries.
    Farioli A; Straif K; Brandi G; Curti S; Kjaerheim K; Martinsen JI; Sparen P; Tryggvadottir L; Weiderpass E; Biasco G; Violante FS; Mattioli S; Pukkala E
    Occup Environ Med; 2018 Mar; 75(3):191-198. PubMed ID: 29133597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.